Hester Biosciences informs about outcome of board meeting

28 Oct 2021 Evaluate
Hester Biosciences has informed that Board of Directors, in its Meeting held today, have approved the followings: Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30 September 2021, as recommended by Audit Committee; Appointment of Priya Gandhi as a Whole-time Director of the Company for the period for 5 (Five) years, subject to approval of members; Appointment of Ameet Desai as an Independent Director of the Company for the period of 5 (Five) years, subject to approval of members. Also attached the approved standalone and consolidated unaudited financial results and limited review reports; and Press Release issued in this regard.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1416.90 -42.85 (-2.94%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×